HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > RNCOS

Print e mail rss del Y! myWeb Tweet
 

Molecular Diagnostic to Show Fastest Growth in IVD Market

Molecular diagnostic market is projected to grow at a CAGR of more than 13% during 2009-2012, propelled by current technological advancements, says RNCOS.

 



(EMAILWIRE.COM, June 30, 2009 ) New Delhi, India - According to our new analytical study, “Global In Vitro Diagnostic Market Analysis”, the current market size of global IVD market is estimated at over US$ 36 Billion, which is forecasted to grow at a CAGR of around 9% through 2012. Molecular Diagnostic, based on its unmatched ability to detect the primary reasons of diseases, is emerging as the fastest growing segment in the In Vitro Diagnostic market. Our research anticipates this growth to be fueled by certain technological advancements which have expanded the segment into new area of diagnosis like genetic screening tests, genetic disorders and many more.

We have found that new developing molecular diagnostic techniques are promising cost reduction in the expenditure in future. This will also help the companies to reduce the cost of tests. Also, high growth projection in this market is attracting more and more companies to make new tests development, which are being done in diagnosis of several drastic diseases.

Anticipating the current market developments and future prospects, molecular diagnostic market is forecasted to grow at a CAGR of more than 13% during 2009-2012. Our research thoroughly analyzes the key markets coupled with factors which are fueling growth into the IVD market. For instance, it says that much of the future growth will be driven by American and European countries as there is more awareness about the tests as compared to Asian countries like India and China. But considering the disease prevalence in these countries, molecular diagnostic segment has a bright future in these countries also.

Looking at the competitive landscape, the larger companies currently dominate most of the molecular testing market. This is because of their immense capability of research. However, introduction of concepts like Intellectual property is expected to encourage the smaller firms to develop and introduce some new tests in the market, to utilize the potential of the segment. Besides this, our report also briefs the segments-wise and region-wise breakup of the global IVD market. The report highlights the key growth factors of other segments as well.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM103.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-11-4214-1229
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Press Release Keywords:

Global In Vitro Diagnostic, Global In Vitro Diagnostic Industry, In Vitro Diagnostics (IVD), Market Research Report, Industry Analysis, Industry Reports, Key Players of In Vitro Diagnostic Industry, Future of In Vitro Diagnostic Industry, Opportunities in In Vitro Diagnostic Industry, Research Report on In Vitro Diagnostic Industry, Analyst View of In Vitro Diagnostic Market, Global Clinical Chemistry Market

Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012